← Open Payments lookup

NPI 1225492788: Open Payments

NPI 1225492788. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$151 in 7 payments from 6 companies in 2025. Trend: 2023 $148 · 2024 $144 · 2025 $151

Food & beverage: $151
CompanyPaymentsAmount
Fresenius USA Marketing, Inc.2$46
AKEBIA THERAPEUTICS INC1$24
Ardelyx, Inc.1$24
AstraZeneca Pharmaceuticals LP1$21
Boehringer Ingelheim Pharmaceuticals, Inc.1$19
Otsuka America Pharmaceutical, Inc.1$18

Products named: VELPHORO, Vafseo, IBSRELA, FARXIGA, JARDIANCE, JYNARQUE.